Literature DB >> 1117993

Effects of L-dopa metabolites at a dopamine receptor suggest a basis for 'on-off' effect in Parkinson's disease.

D Dougan, D Wade, P Mearrick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117993     DOI: 10.1038/254070a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Effects of tetrahydropapaveroline and salsolinol on cerebral monoamine metabolism and their interactions with psychopharmacological drugs.

Authors:  N Awazi; H C Guldberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

Review 2.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

3.  Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actions.

Authors:  R Markstein
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

4.  Treatment of Parkinson's disease: problems with a progressing disease.

Authors:  U K Rinne
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

5.  Early onset of the "on-off" phenomenon in children with symptomatic Parkinsonism.

Authors:  A E Lang; J C Meadows; J D Parkes; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

Review 6.  Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases.

Authors:  P Dostert; M Strolin Benedetti; G Dordain
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

7.  Subacute L-DOPA in mice: biochemical and behavioural effects.

Authors:  O Jenkins; R Bailey; E Crisp; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.